International conferences - American Diabetes Association

1. 1. ADA, 80th Scientific Session, Virtual June 12-16, 2020.
2. Is Time-in-Range Independent of A1C? A Study in Asian Indian Population. Kesavadev J, Shankar A, Krishnan G, Saboo B. D, Sanal G, Krishna M, Sanal T. S, Jothydev S. Diabetes 2020 Jun, 69 (Supplement 1) 880-P; DOI: 10.2337/db20-880-P
   Read More
3. 2. ADA, 79th Scientific Sessions, San Francisco, CA. June 7-11, 2019.
4. Early insulin initiation in T2DM is associated with prevention of eGFR decline and lower insulin dose requirements. Kesavadev J, Warrier R, Shankar A, David A, Ajai N. A, Sanal G, Thampiraj K, Ramachandran L, Krishnan G, Jothydev S. Diabetes 2019 Jun, 68 (Supplement 1) 530-P; DOI: 10.2337/db19-530-P. Link 1 | Link 2
5. Improving the Quality of Life of T1DM Patients in a Community: A KT1DP Initiative. Kesavadev J, Saboo B. D, Shankar A, David A, Warrier R, Ajai N. A, Sanal G, Thampiraj K, Ramachandran L, Krishnan G, Jothydev S. Diabetes Jun 2019, 68 (Supplement 1) 2259-PUB; DOI: 10.2337/db19-2259-PUB. Read More
6. Consistency and Predictability of Control of Glycemic Variability with U200 (Concentrated r-DNA Human Insulin Premix 30/70-200 IU/mL) in Type 2 Diabetes Mellitus Patients. Thacker H, Kesavadev J, Ingole S. A, Shah A, Jain R. Diabetes Jun 2019, 68 (Supplement 1) 2322-PUB; DOI: 10.2337/db19-2322-PUB. Read More
7. 3. ADA, 78th Scientific Sessions, Orlando, Florida, 22 - 26 June, 2018.
8. Are Complications Preventable with Periodic Education via Telemedicine? A Study of 414 Compliant T2D Patients Followed Up for 19 Years. Kesavadev J, Shankar A, David A, Krishnan G, Ajai N. A, Sanal G,Ajith J, Jayanthi S, Ramachandran L, Jothydev S.Diabetes Jul 2018, 67 (Supplement 1) 685-P; DOI: 10.2337/db18-685-P. Link 1 | Link 2 | Link 3
9. IDegAsp Improves Glycemic Control with Minimal Hypoglycemia-An Indian Real-World Study in T2D Subjects. Kesavadev J, Saboo B. D, Shankar A, David A, Warrier R, Krishnan NG, Ramachandran L, Jothydev SDiabetes. 2018 Jun;67(Supplement1). 389-P; DOI: 10.2337/db18-389-P. Link 1 | Link 2 | Link 3 | Link 4
10. Enabling Data-Driven Decision Making for Personalized Care in Type 2 Diabetes with Clinical and Lifestyle Journey Data Using a Digital Therapeutic. Chawla R, Shaikh M, Shah A, Saboo B. D, Makkar B. M, Kesavadev J, Joshi S, Deshpande N, Agarwal S, Maheshwari A, Sosale A. Madhu S. V. Diabetes Jul 2018, 67 (Supplement 1) 248-OR; DOI: 10.2337/db18-248-OR. Link 1 | Link 2
11. Efficacy of a Basal-Plus Regimen. Saboo B. D. J, Hasnani D, Chandarana H, Bhandari S, Joshi S, Kesavadev J, Maheshwari A, Thacker H.Diabetes Jul 2018, 67 (Supplement 1) 2292-PUB; DOI: 10.2337/db18-2292-PUB. Link 1 | Link 2
12. Conversational Artificial Intelligence for Achieving Activity Targets through Routine Physical Activity-Longitudinal Observational Study among People with Type 2 Diabetes. Makkar B. M, Shaikh M, Shah A, Joshi S, Saboo B. D, Sosale A. R, Madhu S. V, Kovil R, Shah T, Chawla M. S, Chawla R, Kesavadev J.Diabetes Jul 2018, 67 (Supplement 1) 750-P; DOI: 10.2337/db18-750-P. Link 1 | Link 2 | Link 3
13. One-Year Safety and Effectiveness of Insulin Degludec in Patients with Diabetes Mellitus in Routine Clinical Practice in India-TRUST (Tresiba Real-World Use Study). Kesavadev J, Murthy L. S, Saboo B. D, Yalamanchi S. R, Ramanathan B, Gupta S, Chatterjee S, Revanna M, Kasetty H. Diabetes Jul 2018, 67 (Supplement 1) 1019-P; DOI: 10.2337/db18-1019-P.
    Link 1 | Link 2
14. Continuous Glucose Monitoring Guided Assessment of Concentrated U200 r-DNA Human Premix 30/70 Insulin. Thacker H, Kesavadev J, Singh G, Shukla K, Puppalwar G, Shrimanker R. Diabetes Jul 2018, 67 (Supplement 1) 1013-P; DOI: 10.2337/db18-1013-P. Link 1 | Link 2 | Link 3
15. Real-World Effectiveness of a Digital Therapeutic in Improving Glycaemic Control in South Asians Living with Type 2 Diabetes. Sosale A. R, Sr., Shaikh M, Shah A, Chawla R, Makkar B. M, Kesavadev J, Joshi S, Deshpande N, Agarwal S, Maheshwari A, Madhu S, Saboo B. D. Read More
16. 4. ADA, 77th Scientific Sessions, San Diego, California, June 9-13, 2017.
17. Halting CKD Progression in Diabetes with Virtual Interactions- a 5 year Retrospective Analysis. Kesavadev J, Shankar A, Sanal G, Ramachandran L, Krishnan G, Jothydev S. Diabetes 2017 Jun, 66 (Supplement 1) 2282- PUB; DOI: 10.2337/db17-2282- PUB. Read More
18. Use of Flash Glucose Monitor to Optimize the Dose of Basal Insulin Glargine-Real-World Clinical Data. Patel F, Goklani R, Saboo B, Hasnani D, Maheshwari A, Kesavadev J, Joshi S. R. Diabetes 2017 Jun, 66 (Supplement 1) 939 P; DOI: 10.2337/db17- 939 P. Link 1 | Link 2
19. Sharing the Outcomes and User Experience from India in The First 750 Type 2 Diabetes Patients with the New Libre Pro 14-Day Glucose Sensor. Kesavadev J, Ramachandran L, Shankar A, David A, Krishnan G, Srinivas S, Ajai A, Sanal G, Jothydev S. Diabetes 2017 Jun, 66 (Supplement 1) LB27-LB28; DOI: 10.2337/db17- LB27-LB28.
    Link 1 | Link 2 | Link 3
20. The significance of repeated education in correcting insulin injection techniques and improving glycemic control. Kesavadev J, David A, Shankar A, Sowmya J, Ramachandran L, Krishnan G ,Jothydev S. Diabetes 2017 Jun, 66 (Supplement 1) 716-P; DOI: 10.2337/db17- 716-P. Link 1 | Link 2 | Link 3
21. Validation for Artificial Intelligence Leveraging Patient-Centric User Experience for Behavior Change in Subjects with Type 2 Diabetes. Aravind S. R, Saboo B. D, Shah T, Joshi S. S, Shaikh M, Subnis U, Shah A, Kesavadev J. Diabetes 2017 Jun, 66 (Supplement 1) 367 OR; DOI: 10.2337/db17- 367 OR. Link 1 | Link 2 | Link 3
22. 5. ADA, 76th Scientific Sessions, New Orleans, Louisiana June 10-14, 2016.
23. Comparison of the New Factory Calibrated Sensor with Existing CGM Sensor. Kesavadev J, Pillai P. B. S, Shankar A, Ashok A.D, Sanal G, Iyer R, Krishnan G, Jothydev S. Diabetes 2016 Jun, 65 (Supplement 1) P896; DOI: 10.2337/db16- P896.
    Link 1 | Link 2 | Link 3
24. How Successful Is Lifestyle Advice in Preventing the Progression of Prediabetes to Diabetes? Kesavadev J, Shankar A, Pillai P. B. S, Lally J, Krishnan G, Sanal G, Jothydev S.Diabetes 2016 Jun, 65 (Supplement 1) 724-P; DOI: 10.2337/db16- 724-P. Link 1 | Link 2 | Link 3
25. 6. ADA, 75th Scientific Sessions, Boston, Massachusetts, June 5-9, 2015.
26. Utilization of Biosimilar insulin in Asian patients with diabetes - The Joint Asia Diabetes Evaluation (JADE) program. Gani L. U, Lau E, Luk A, Sobrepena L, Tran Q. K, Kesavadev J, Jia W, Chan J. C. N. Diabetes 2015 Jun, 64 (Supplement 1) P1023; DOI: 10.2337/db15- P1023. Link 1 | Link 2
27. Exploring and resolving the impact of food on post prandial glycemic excursions in a rice-eating population in S. India. Kesavadev J, Shankar A, Sanal G, Ajai N. A, Krishnan G,Jothydev S. Diabetes 2015 Jun, 64 (Supplement 1) A623-A635; DOI: 10.2337/db15- A623-A635. 2486-PO. Link 1 | Link 2
28. Periodic CGM in T2DM: exploring benefits across various therapy choices. Kesavadev J, Pillai P. B. S, Shankar A, Sanal G, Lally J, Krishnan G, Jothydev S. Diabetes 2015 Jun, 64 (Supplement 1) P964; DOI: 10.2337/db15- P964. Link 1 | Link 2
29. Insulin-sparing effect of and Severe Hypoglycemia with Sitagliptin vs. Glimepiride. Kesavadev J, Pillai P. B. S, Shankar A, Krishnan G, Jothydev S. Diabetes 2015 Jun, 64 (Supplement 1) PO2486; DOI: 10.2337/db15- PO2486. Read More
30. Comparing two models of diabetes care comprehensive education and telemonitoring vs. limited care. Kesavadev J, Vitale R, Babu P, Pillai S, Krishnan G, Jothydev S. Diabetes 2015 Jun, 64 (Supplement 1) P743; DOI: 10.2337/db15- P743.
    Link 1 | Link 2
31. 7. ADA, 74thScientific Sessions, San Francisco, California, June 13 - 17, 2014.
32. Continuous Glucose Monitoring in 432 T2D Patients for Assessment of Safety and Cost effectiveness in Reaching A1C Targets. Kesavadev J, Shankar A, Lally J, Sanal G, Gopalakrishnan G, Jothydev S. Diabetes 2014 Jun, 63 (Supplement 1) P398; DOI: 10.2337/db14- P398. Link 1 | Link 2 | Link 3 | Link 4
33. 8. ADA, 73thScientific Sessions, Chicago, Illinois, June 21-25, 2013.
34. Time of Insulin Initiation, Duration of disease and onset of Erectile Dysfunction in Indian men with T2D. Shankar A, Jothydev S, Gopalakrishnan G, Lally J, Kesavadev J. Diabetes 2013 Jun, 62 (Supplement 1) PO2737; DOI: 10.2337/db13- PO2737. Link 1 | Link 2
35. Long Term Impact of Initial Insulin Therapy in New Onset T2D: 5 year Retrospective Data. Kesavadev J, Shankar A, Gopalakrishnan G, Jothydev S.Diabetes 2013 Jun, 62 (Supplement 1) PO2552; DOI: 10.2337/db13- PO2552. Link 1 | Link 2
36. Superiority of a Telemedicine Based Counselling in Ensuring Multi Drug Compliance in T2D. Kesavadev J, Shankar A, Gopalakrishnan G, Lally J, Sanal G, Jothydev S. Diabetes 2013 Jun, 62 (Supplement 1) 698-P; DOI: 10.2337/db13- 698-P.
    Link 1 | Link 2 | Link 3
37. Normal Vitamin D Levels Correlates with Lower HbA1c: A Cross Sectional Study Among 1270 Type 2 Diabetes Patients in South India. . Gopalakrishnan G, Pillai P. B. S, Shankar A, Jothydev S, Kesavadev J. Diabetes 2013 Jun, 62 (Supplement 1) PO2763; DOI: 10.2337/db13- PO2763. Link 1 | Link 2
38. 9. ADA, 72th Scientific Sessions, Philadelphia, Pennsylvania, June 8-12, 2012.
39. High Bed Time Glucose and Early Morning Low Sugars in Elderly Subjects with Type 2 Diabetes (T2DM): An Incidental Finding with Clinical Significance. Kesavadev J, Shankar A, Lally J, Sanal G, Gopalakrishnan G, Jothydev S. Diabetes 2012 Jun, 61 (Supplement 1) 881-P; DOI: 10.2337/db12- 881-P. Link 1 | Link 2
40. Patterns of Glycemic variability (GV) in Indian Type 2 diabetes (T2DM) patients on Insulin and Oral Hypoglycemic Agents (OHAs) and its Correlation with A1c and Hypoglycemia. Kesavadev J, Pillai P. B. S, Shankar A, Sanal G, Lally J, Gopalakrishnan G, Jothydev S.Diabetes 2012 Jun, 61 (Supplement 1) 2343-PO; DOI: 10.2337/db12- 2343-PO. Read More
41. Efficacy and Safety of Liraglutide in 195 Patients with Type 2 Diabetes in India: A Retrospective Analysis. Kesavadev J, Shankar A, Gopalakrishnan G, Veeresh B, Jothydev S.Diabetes 2012 Jun, 61 (Supplement 1) 2403-PO; DOI: 10.2337/db12- 2403-PO. Read More
42. 10. ADA, 71th Scientific Sessions, San Diego, California, June 24-28, 2011.
43. A1c, BP and LDL Goals - Successful Use of Telemedicine (DTMS®) in 1000 Compliant T2DM Subjects over 6 Months. Kesavadev J, Babu P, Pillai S, Shankar A, Dinkar G, Lally J, Sanal G, Gopalakrishnan G, Jothydev S.Diabetes 2011 Jun, 60 (Supplement 1) 229- OR; DOI: 10.2337/db11- 229- OR.
    Link 1 | Link 2
44. Significance of Screening for Thyroid Disorders in Type 2 Diabetes. Kesavadev J, Pillai P. B. S, Shankar A, Gopalakrishnan G, Jothydev S. Diabetes 2011 Jun, 60 (Supplement 1) P1377; DOI: 10.2337/db11- P1377. Link 1 | Link 2
45. Utility of CGM over Conventional SMBG in Making Treatment Changes in Insulin Requiring T2DM Patients. Kesavadev J, Pillai P. B. S, Shankar A, Gopalakrishnan G, Sanal G, Lally J, Jothydev S.Diabetes 2011 Jun, 60 (Supplement 1) 912 P; DOI: 10.2337/db11- 912 P. Link 1 | Link 2
46. Change in Antihypertensive Medication Dose Following Initiation of Liraglutide in Patients. Kesavadev J, Shankar A, Gopalakrishnan G, Jothydev S. Diabetes 2011 Jun, 60 (Supplement 1) 2357-PO; DOI: 10.2337/db11- 2357-PO.
    Link 1 | Link 2
47. 11. ADA, 70th Scientific Sessions, Orlando, June 25-29, 2010.
48. Telefollow up and SMBG Via "DTMS"- A Cost Effective Tool for A1c Lowering. Kesavadev J, Shankar A, Shamsudeen J, Dinkar G, Pillai B. S, Gopalakrishnan G, Ajai N, Sathish J, Jothydev S. Diabetes 2010 Jun, 59 (Supplement 1) 2083-PO; DOI: 10.2337/db10- 2083-PO. Read More
49. High Prevalence of Elevated Transaminases among T2DM in S.India. Kesavadev J, Shankar A, Pillai P. B. S, Suresh P, Gopalakrishnan G, Jothydev S. Diabetes 2010 Jun, 59 (Supplement 1) 2340-PO; DOI: 10.2337/db10- 2340-PO. Read More
50. Cost-Effectiveness of Education Via "DTMSTM" and Achievement of Goals: Evidence Over a Decade. Oral Presentation - Speaker: Dr.JothydevKesavadev, June, 2010.
51. Advanced Pump Training in Type 2 Diabetes: Pros & Cons. Oral Presentation, Speaker: Gopika Krishnan, June, 2010.
52. 12. ADA, 69th Scientific Sessions, New Orleans, USA, June 5-9, 2009.
53. Role of Continuous Glucose Monitoring in Modifying Diet and Lifestyles in Diabetes subjects. Kesavadev J, Shamsudeen J, Badarudeen S, Jothydev S, Dinkar G. Oral Presentation, Speaker: Dr.JothydevKesavadev. Diabetes 2009 Jun, 58 (Supplement 1) 268-OR; DOI: 10.2337/db09- 268-OR. Read More
54. Requirement of High Dosage of Insulin in Previous Users of Glibenclamide with Uncontrolled Diabetes. Kesavadev J, Shamsudeen J, Badarudeen S, Simon N. A, Jothydev S. Diabetes 2009 Jun, 58 (Supplement 1) PO2079; DOI: 10.2337/db09- PO2079. Read More
55. Indian Patients with Diabetes Experienced Better Glycemic Control, Less Weight Gain and Hypoglycaemia with Insulin Detemir When Switched from NPH and Insulin Glargine in PREDICTIVE® Study. Kesavadev J, Singh P, Pitle S. U, Bhattacharyya A, Mayya R, Moharana A. K, Pathak A, Kalra S. Diabetes 2009 Jun, 58 (Supplement 1) PO2053; DOI: 10.2337/db09- PO2053. Read More
56. 13. ADA, 68th Scientific Sessions, San Francisco, USA, June 6-8, 2008.
57. Experiences with Insulin Pump in 52 Patients with Type 2 Diabetes in India. Kesavadev J, Kumar A, Ahammed S, Jothydev S.Diabetes 2008 Jun, 57 (Supplement 1) PO2021; DOI: 10.2337/db08- PO2021. Read More
58. Insulin Aspart Induced Lipoatrophy in a Patient on Insulin Pump. Kesavadev J, Kumar A, Ahammed S, Dinkar G, Jothydev S. Diabetes 2008 Jun, 57 (Supplement 1) PO2093; DOI: 10.2337/db08- PO2093. Read More
59. High Prevalence of Dyslipidemia and Hypertension Detected in a Screening Program for Diabetes in a Rural population of a Southern State in India, Kerala. Kumar A, Kesavadev J, Ahammed S, Dinkar G, Jothydev S.Diabetes 2008 Jun, 57 (Supplement 1) 2424-PO; DOI: 10.2337/db08- 2424-PO. Read More
60. A Study on the Effects of Acarbose in Reducing Post-Prandial Blood Glucose and Achieving HbA1c. Ahammed S, Kumar A, Gopi D. K, Kesavadev J. Diabetes 2008 Jun, 57 (Supplement 1) 438-P; DOI: 10.2337/db08- 438-P.
    Link 1 | Link 2
61. 14. ADA, 67th Scientific Sessions, Chicago, June 22-26, 2007.
62. Achieving Desirable Glycemic Targets without the risks of Hypoglycemia using a Teletitration program. Kesavadev J, Rasheed S. A, Nair D. R. Diabetes 2007 Jun, 56 (Supplement 1) 0421-P; DOI: 10.2337/db07- 0421-P.
    Link 1 | Link 2
63. Dramatic Response of Painful Peripheral Neuropathy with Insulin Pump in Type 2 Diabetes. Kesavadev J, Rasheed S. A.Diabetes 2007 Jun, 56 (Supplement 1) 2097-PO; DOI: 10.2337/db07- 2097-PO. Read More